Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Healthstream (HSTM) Shares Repurchased (2020 - 2026)

Healthstream has reported Shares Repurchased over the past 6 years, most recently at $5.0 million for Q4 2025.

  • Quarterly Shares Repurchased changed N/A to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, up 33.28% year-over-year, with the annual reading at $30.0 million for FY2025, N/A changed from the prior year.
  • Shares Repurchased was $5.0 million for Q4 2025 at Healthstream, down from $6.9 million in the prior quarter.
  • Over five years, Shares Repurchased peaked at $19.7 million in Q1 2022 and troughed at $1.6 million in Q3 2023.
  • The 4-year median for Shares Repurchased is $5.0 million (2021), against an average of $7.0 million.
  • The largest YoY upside for Shares Repurchased was 36.57% in 2021 against a maximum downside of 36.57% in 2021.
  • A 4-year view of Shares Repurchased shows it stood at $5.0 million in 2021, then tumbled by 37.36% to $3.1 million in 2022, then surged by 132.1% to $7.3 million in 2023, then plummeted by 31.27% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Shares Repurchased are $5.0 million (Q4 2025), $6.9 million (Q3 2025), and $7.3 million (Q4 2023).